Fernández-Real JM - Search Results

1

Serum visfatin increases with progressive beta-cell deterioration.

López-Bermejo A, Chico-Julià B, Fernàndez-Balsells M, Recasens M, Esteve E, Casamitjana R, Ricart W, Fernández-Real JM. López-Bermejo A, et al. Diabetes. 2006 Oct;55(10):2871-5. doi: 10.2337/db06-0259. Diabetes. 2006. PMID: 17003355

2

Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus.

Fernandez-Real JM, Lainez B, Vendrell J, Rigla M, Castro A, Peñarroja G, Broch M, Pérez A, Richart C, Engel P, Ricart W. Fernandez-Real JM, et al. Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E952-9. doi: 10.1152/ajpendo.00444.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 11882518 Free article.

3

Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function.

Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Fernández-Real JM, et al. Diabetes. 2002 Apr;51(4):1000-4. doi: 10.2337/diabetes.51.4.1000. Diabetes. 2002. PMID: 11916918 Clinical Trial.

4

Cross-talk between iron metabolism and diabetes.

Fernández-Real JM, López-Bermejo A, Ricart W. Fernández-Real JM, et al. Diabetes. 2002 Aug;51(8):2348-54. doi: 10.2337/diabetes.51.8.2348. Diabetes. 2002. PMID: 12145144 Review.

5

Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study.

Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J, Ricart W. Fernandez-Real JM, et al. J Clin Endocrinol Metab. 2002 Oct;87(10):4686-90. doi: 10.1210/jc.2001-011843. J Clin Endocrinol Metab. 2002. PMID: 12364459

6

Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity.

Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, López-Bermejo A, Ricart W. Fernández-Real JM, et al. Diabetes Care. 2002 Dec;25(12):2249-55. doi: 10.2337/diacare.25.12.2249. Diabetes Care. 2002. PMID: 12453969 Clinical Trial.

7

G protein beta3 gene variant, vascular function, and insulin sensitivity in type 2 diabetes.

Fernández-Real JM, Peñarroja G, Richart C, Castro A, Vendrell J, Broch M, López-Bermejo A, Ricart W. Fernández-Real JM, et al. Hypertension. 2003 Jan;41(1):124-9. doi: 10.1161/01.hyp.0000042428.24031.73. Hypertension. 2003. PMID: 12511541 Clinical Trial.

8

CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.

Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W. Fernández-Real JM, et al. J Clin Endocrinol Metab. 2003 Apr;88(4):1780-4. doi: 10.1210/jc.2002-020173. J Clin Endocrinol Metab. 2003. PMID: 12679473

9

Insulin resistance, inflammation, and serum fatty acid composition.

Fernández-Real JM, Broch M, Vendrell J, Ricart W. Fernández-Real JM, et al. Diabetes Care. 2003 May;26(5):1362-8. doi: 10.2337/diacare.26.5.1362. Diabetes Care. 2003. PMID: 12716789

10

[Impact of hormonal deficit and cardiovascular risk factors on life expectancy in hypopituitarism].

Ricart W, Fernández-Real JM. Ricart W, et al. Med Clin (Barc). 2003 May 3;120(16):630-7. doi: 10.1016/s0025-7753(03)73792-0. Med Clin (Barc). 2003. PMID: 12732130 Review. Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters